Literature Search Strategy Used for the MEDLINE Database Gami AS, et al. J Am Coll Cardiol 2007;49:403-14.

Slides:



Advertisements
Similar presentations
Sibbing D, et al. J Am Coll Cardiol 2009;53:
Advertisements

Baseline Characteristics According to CET Rate Marianne Zeller, et al. J Am Coll Cardiol 2007;50:
Admission B-Type Natriuretic Peptide Levels and In-Hospital Mortality in Acute Decompensated Heart Failure Fonarow GC et al. J Am Coll Cardiol 2007; 49(19):
Flow chart showing number of citations retrieved by individual searches and number of trials included in review Strippoli GF, et al. BMJ 2008 Feb 25 [Epub.
FAME 2 year Objective:To investigate the 2-year outcome of PCI guided by FFR in patients with multivessel CAD. Study:Multicenter, single blind, randomized.
Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose? Systolic.
Impact of Socioeconomic Status on Cardiovascular Disease and Mortality in 24,947 Individuals With Type 1 Diabetes Featured Article: Araz Rawshani, Ann-Marie.
S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial Efficacy and safety of ivabradine in patients with severe chronic systolic.
WOSCOPS: West Of Scotland Coronary Prevention Study Purpose To determine whether pravastatin reduces combined incidence of nonfatal MI and death due to.
Patient disposition Dichtl W, et al. Am J Cardiol. 2008;102:743-8 AVR = aortic valve replacement; MDCT = multidetector computed tomographic.
Hsia J et al. J Am Coll Cardiol 2011;57: Baseline Characteristics by Treatment Group and Attained LDL-C Hsia J et al. J Am Coll Cardiol 2011;57:
Distribution of metabolic syndrome (MS) components by age and gender Zhao D, et al. Am J Cardiol 2007;100:835– 839.
Flow diagram of the systematic literature search indicating the inclusion and exclusion process of studies Liakopoulos OJ, et al. Eur Heart J 2008;29:
Baseline Characteristics of 987 Individuals With Stable Coronary Heart Disease by Amino Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide.
Trial profile Prakash Deedwania, et al. Lancet 2006; 368:
Charmaine J. Palafox, MD. Approx. 50% of CHD deaths occurs as sudden cardiac arrest.
Enrollment and Outcomes Duckworth W, et al. N Engl J Med 2009;360:
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Omega-3 Polyunsaturated Fatty Acids and Cardiovascular.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effects of Habitual Coffee Consumption on Cardiometabolic.
The SYMPHONY Trial Reference Reddan DN, et al. Renal function, concomitant medication use and outcomes following acute coronary syndromes. Nephrol Dial.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prognostic Value of Cardiac Computed Tomography.
Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Hypertension J Am Coll Cardiol. 2006;48(8):
Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Drug-Eluting Versus Bare-Metal Stents During PCI.
Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prevalence and Clinical Implications of Newly Revealed,
Date of download: 6/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: The metabolic syndrome, diabetes, and subclinicalatherosclerosis.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Atherothrombosis J Am Coll Cardiol. 2012;60(10):
Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Asymptomatic Individuals With a Positive Family.
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
Clinical need for determination of vulnerable plaques
Nat. Rev. Cardiol. doi: /nrcardio
Comparison of baseline characteristics in participants who subsequently had an incident cardiovascular event or new-onset diabetes in the Prospective.
Clinical Characteristics
TNT: Baseline and final LDL cholesterol levels
Creatinine clearance (mL/min) n All-cause mortality (%)
Figure 4 BMI and mortality in patients with heart failure
Baseline characteristics of patients
Nat. Rev. Cardiol. doi: /nrcardio
Figure 2 Three-year survival rates on the basis of body composition
Impact of Cognitive Function Change on Mortality in Renal Transplant and End-Stage Renal Disease Patients Sharma et al. Am J Nephrol 2016;44: (DOI: / )
INOVATE-HF Trial design: Patients with heart failure (HF) were randomized to device implant for vagus nerve stimulation (n = 436) versus optimal medical.
Figure 4 Effects of delaying cardioprotective medications after anthracycline administration Figure 4 | Effects of delaying cardioprotective medications.
Nat. Rev. Cardiol. doi: /nrcardio
Figure 1.Flowchart of the article-selection process.
MACE rate among CAD severity groups (total 0
Description of studies for pooled analyses
Fung TT, et al. Circulation 2009;119:
Figure 4 Observational studies on multiple treatment strategies
Baseline Characteristics of Cardiovascular Risk Factors and Selected Dietary Variables in a Cohort of 22,881 Men and 35,091 Women to Quintile of Fish Intakes.
Baseline Characteristics by Baseline N-BNP Level
Baseline Characteristics by Tertiles of Homocysteine
Berger JS, et al. JAMA 2009;301:
Nat. Rev. Cardiol. doi: /nrcardio
Characteristics of 21,484 Patients With MI Who Survived for >30 Days After Discharge, by Calendar Year - Part I Soko Setoguchi, et al. J Am Coll Cardiol.
Flow Diagram of the Trial Selection Process
Baseline Patients with coronary artery disease (CAD) and high (n=98) versus normal (n=1512) high-density lipoprotein (HDL) levels Doreen DeFaria Yeh, et.
Baseline Characteristics of Study Subjects
Nat. Rev. Cardiol. doi: /nrcardio
Baseline characteristics for patients with diabetes in ASCOT-LLA Part I P.S. SEVER et al Diabetes Care 2005; 28: 1151–1157.
Baseline Characteristics
Emerging Risk Factors Collaboration. JAMA 2009;302:412-23
Baseline Characteristics of the Patients – Part I
Baseline Characteristics by hs-CRP
Cox regression of proportion mortality in the first 8 years for patients with three-vessel disease with a significant difference between the treatment.
Incidence of contrast-induced nephropathy in patients with CKD, normal kidney function and all patients. Incidence of contrast-induced nephropathy in patients.
Baseline characteristics of the 1,842 men without coronary heart disease and the 230 men with a first coronary heart disease event during the 13-year.
EMPA-REG OUTCOME: Cumulative incidence of the primary outcome
Baseline characteristics of study population
Demographic Characteristics of Patients Treated With Statins Versus Those Not Treated With Statins Goldberger JJ, et al. J Am Coll Cardiol 2006;48:
Multivariate-adjusted HRs (95% CI) for deaths from CV disease (CVD), coronary heart disease (CHD), stroke, and all-cause mortality according to fasting.
Risk differences for incident stroke, coronary heart disease (CHD), and cardiovascular mortality (per 1000 person-years) by clinical risk factor in the.
Presentation transcript:

Literature Search Strategy Used for the MEDLINE Database Gami AS, et al. J Am Coll Cardiol 2007;49:403-14

Flowchart of Article Inclusion *The 36 included articles described 37 studies that included 43 unique cohorts Gami AS, et al. J Am Coll Cardiol 2007;49:403-14

Characteristics of Cohort Studies of Metabolic Syndrome and Incident Cardiovascular Disease and Death - Part I Gami AS, et al. J Am Coll Cardiol 2007;49:403-14

Characteristics of Cohort Studies of Metabolic Syndrome and Incident Cardiovascular Disease and Death - Part II Gami AS, et al. J Am Coll Cardiol 2007;49:403-14

Characteristics of Cohort Studies of Metabolic Syndrome and Incident Cardiovascular Disease and Death - Part III Gami AS, et al. J Am Coll Cardiol 2007;49:403-14

RR and 95% CI for Metabolic Syndrome and Incident Cardiovascular Events and Death, by Specific Outcomes Gami AS, et al. J Am Coll Cardiol 2007;49:403-14

RR and 95% CI for Metabolic Syndrome and Incident Cardiovascular Events and Death Gami AS, et al. J Am Coll Cardiol 2007;49:403-14

RR and 95% CI for Metabolic Syndrome and Incident Cardiovascular Events and Death in Studies That Simultaneously Included Metabolic Syndrome and Some of its Components Into Multivariable Models Gami AS, et al. J Am Coll Cardiol 2007;49:403-14

RR and 95% CI for Incident Coronary Heart Disease Events in Patients Without Prevalent Cardiovascular Disease Gami AS, et al. J Am Coll Cardiol 2007;49:403-14

Publication Bias and Its Potential Impact Gami AS, et al. J Am Coll Cardiol 2007;49:403-14

References Gami AS, et al. J Am Coll Cardiol 2007;49:403-14

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.